ICD-10 Codes for Autoimmune Encephalitis

Imagine a vibrant young woman who, over the course of days, transforms from a university student into someone experiencing intense psychosis, bizarre movements, and seizures. Or a middle-aged man who begins to have profound short-term memory loss, as if the fabric of his recent past is being erased. These are not scenes from a medical drama; they are the real-world presentations of autoimmune encephalitis (AE), a devastating but treatable group of conditions where the body’s own immune system mistakenly attacks the brain. For clinicians, the battle is fought on the front lines of diagnosis and treatment—a race against time to calm the immune system and save brain function. But behind the scenes, another critical process unfolds: the translation of this complex clinical narrative into the precise, standardized language of medical codes. This is where the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) comes in.

Accurate ICD-10 coding for autoimmune encephalitis is far from a mere administrative task. It is a vital linchpin connecting patient care to the wider healthcare ecosystem. It influences hospital reimbursement, drives public health surveillance and research, and helps identify trends in this rare disease. A correctly assigned code ensures that the resources required for the intensive care these patients often need are appropriately funded. Conversely, an inaccurate code can obscure the true incidence of AE, hinder research efforts, and lead to significant financial repercussions for healthcare institutions. This article serves as a definitive guide, bridging the gap between the clinical intricacies of autoimmune encephalitis and the precise requirements of the ICD-10-CM coding system. We will delve deep into the codes themselves, explore complex coding scenarios, and emphasize why specificity is not just a coding best practice but a necessity for accurately representing these patients’ journeys.

2. Understanding Autoimmune Encephalitis: A Clinical Primer for the Coder

To code a disease accurately, one must first understand it. For medical coders, a foundational knowledge of autoimmune encephalitis is essential for interpreting provider documentation and selecting the most specific codes.

What is Autoimmune Encephalitis?
Autoimmune encephalitis is a broad term for a group of disorders characterized by inflammation of the brain parenchyma caused by an autoimmune response. Unlike infectious encephalitis (e.g., herpes simplex virus), where a pathogen directly invades the brain, in AE, the body produces antibodies that target its own brain proteins. These proteins can be on the surface of neurons (e.g., NMDA receptors, LGI1) or within the cell (intracellular; e.g., Hu, Yo). Surface antibody syndromes are often highly responsive to immunotherapy, while intracellular antibody syndromes are frequently paraneoplastic and have a poorer prognosis.

The Spectrum of Disease: From Limbic Encephalitis to Anti-NMDAR Encephalitis
AE is not a single entity but a spectrum. Some common types include:

• Anti-NMDA Receptor Encephalitis: Perhaps the most well-known type, often associated with ovarian teratomas. It presents with a characteristic syndrome of psychosis, memory deficits, speech issues, seizures, abnormal movements, autonomic instability, and decreased consciousness.

• Limbic Encephalitis: Affects the limbic system (hippocampus, amygdala), leading to severe short-term memory loss, seizures, and confusion.

• LGI1 Antibody Encephalitis: Often presents with faciobrachial dystonic seizures (brief, shock-like movements of the face and arm), hyponatremia, and cognitive changes.

• CASPR2 Antibody Encephalitis: Can present with limbic encephalitis, neuromyotonia (muscle twitching), and Morvan’s syndrome (a combination of peripheral nerve hyperexcitability and autonomic/central nervous system dysfunction).

Signs, Symptoms, and Diagnostic Challenges
The presentation of AE is notoriously heterogeneous, often mimicking psychiatric illnesses, drug abuse, or viral encephalitis. Key symptoms include:

• Cognitive Dysfunction: Rapidly progressing memory loss, especially short-term.

• Psychiatric Symptoms: Anxiety, depression, agitation, hallucinations, psychosis, and bizarre behavior.

• Seizures: Focal or generalized tonic-clonic seizures.

• Movement Disorders: Oro-facial dyskinesias, chorea, catatonia.

• Autonomic Dysfunction: Fluctuating blood pressure, heart rate, and temperature.

• Speech Problems: Pressured speech, reduced verbal output, or mutism.

Diagnosis is challenging and requires a high index of suspicion. The time from symptom onset to diagnosis can be prolonged, leading to worse outcomes.

The Diagnostic Arsenal: MRI, EEG, Lumbar Puncture, and Antibody Testing
A multifaceted approach is used for diagnosis:

1. MRI Brain: May show increased T2/FLAIR signal in specific regions like the medial temporal lobes (in limbic encephalitis) or be entirely normal.

2. EEG (Electroencephalogram): Almost always abnormal, showing slow or disorganized activity; may show epileptic activity.

3. Lumbar Puncture (Spinal Tap): Crucial test. Typically shows cerebrospinal fluid (CSF) pleocytosis (elevated white blood cells) and/or elevated protein. The presence of CSF-specific oligoclonal bands supports an inflammatory process.

4. Antibody Testing: The definitive test. Serum and CSF are sent for panels testing for neural autoantibodies. Testing both increases sensitivity, as some antibodies (like anti-NMDAR) are more reliably detected in the CSF.

3. The Foundation of Medical Coding: Navigating the ICD-10-CM System

Purpose and Importance of Accurate Coding
ICD-10-CM codes are alphanumeric designations used to represent diagnoses and reasons for encounters with the healthcare system. Their purposes are multifold:

• Reimbursement: They are the primary drivers of diagnosis-related group (DRG) assignment for inpatient stays and are critical for justifying medical necessity for outpatient services and procedures.

• Epidemiology and Public Health: They track disease incidence, prevalence, and outcomes, informing resource allocation and research priorities.

• Clinical Research: Researchers use coded data to identify patient cohorts for studies on disease natural history and treatment efficacy.

• Quality Metrics: Codes are used to measure healthcare outcomes and hospital performance.

Structure of an ICD-10-CM Code
Understanding the code structure aids in finding the correct code.

• Category (Characters 1-3): The code starts with a letter followed by two numbers (e.g., G04 represents encephalitis, myelitis and encephalomyelitis).

• Etiology/Anatomic Site (Characters 4-6): These provide greater specificity regarding the cause, manifestation, or location (e.g., G04.81 specifies “other encephalitis and encephalomyelitis due to other causes”).

• Extension (Character 7): This is an important placeholder, often an ‘X’ for future expansion or a digit providing further detail (e.g., laterality, encounter type).

The Role of Official Guidelines and Coding Clinics
The ICD-10-CM Official Guidelines for Coding and Reporting are the definitive rules for code assignment. They are updated annually and must be followed. Additionally, the AHA Coding Clinic for ICD-10-CM provides official advice on specific, complex coding scenarios. For example, Coding Clinic has provided crucial guidance on how to code antibody-negative autoimmune encephalitis. Relying on memory or unofficial sources is a major pitfall; the coder must always consult these authoritative resources.

4. The Core of the Matter: Specific ICD-10 Codes for Autoimmune Encephalitis

The journey to the correct code begins in the ICD-10-CM manual’s Alphabetic Index.

G04.81 – Other encephalitis and encephalomyelitis due to other causes
This is the central code for most types of autoimmune encephalitis.

• Path through the Alphabetic Index:

  • Look up the main term: Encephalitis.

  • Scan the subterms. You will not find a specific subterm for “autoimmune.” Instead, you look for the etiology.

  • If the documentation specifies a type (e.g., “limbic”), see: Encephalitis -> limbic -> G04.81.

  • If the documentation simply states “autoimmune encephalitis,” see: Encephalitis -> autoimmune -> G04.81.

  • The index also directs you from Encephalomyelitis -> autoimmune -> G04.81.

• Verification in the Tabular List:

  • Always verify the code in the Tabular List (the numerical list). This is non-negotiable.

  • Navigate to category G04 Encephalitis, myelitis and encephalomyelitis.

  • Find the code G04.81 Other encephalitis and encephalomyelitis due to other causes.

  • Crucially, note the instruction: “Code also the underlying cause, if known.” This is the key to accurate and specific coding for AE.

This instruction mandates that you must assign an additional code to identify the specific antibody or etiology if it is documented.

5. Beyond the Basics: The Critical Role of Antibody Specificity

The code G04.81 alone is often insufficient. The true power and precision of coding for AE come from identifying and coding the underlying cause.

Coding the Cause: The Importance of the Etiology Code
The “code also” instruction under G04.81 directs you to codes from other chapters. For autoimmune encephalitis, the cause is typically an autoantibody, which is classified in Chapter 4: Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89). The most relevant category is D89.89 – Other specified disorders involving the immune mechanism, not elsewhere classified.

This code is used as a “holder” that must be further specified with an additional code from the R79.8- series to identify the specific antibody.

Common Antibody Associations and Their Codes
The following table outlines common autoantibodies and their corresponding ICD-10-CM codes. This is where clinical documentation becomes paramount.

 ICD-10-CM Codes for Common Autoimmune Encephalitis Antibodies

Key: FBDS = Faciobrachial Dystonic Seizures

As shown, the code R79.83 – Abnormal tumor marker is used to represent the presence of a specific neural autoantibody. This might seem counterintuitive, as these are not traditional “tumor markers” like PSA or CA-125. However, per ICD-10-CM indexing and guidelines, this is the designated code for this purpose.

6. Coding Scenarios: From Documentation to Final Code Assignment

Let’s apply this knowledge to realistic clinical documentation.

Scenario 1: Confirmed Anti-NMDAR Encephalitis

• Documentation: “Patient is a 22-year-old female admitted with acute onset of confusion, bizarre behavior, and orofacial dyskinesias. CSF studies showed lymphocytic pleocytosis and positive CSF anti-NMDA receptor antibodies. MRI brain was unremarkable. Patient was treated with IV methylprednisolone and IVIG with gradual improvement.”

• Coding Process:

  1. The manifestation is encephalitis -> G04.81

  2. The cause is an immune disorder involving a specific antibody -> D89.89

  3. The specific antibody is anti-NMDAR -> R79.83

• Final Code Assignment: G04.81, D89.89, R79.83

Scenario 2: Suspected Autoimmune Encephalitis, Antibody-Negative

• Documentation: “Patient presents with subacute cognitive decline and seizures. Infectious workup negative. MRI shows bilateral medial temporal lobe T2 FLAIR hyperintensity suggestive of limbic encephalitis. Full autoimmune and paraneoplastic antibody panel (serum and CSF) returned negative. Patient responded well to empiric IV steroids. Diagnosis: Seronegative autoimmune limbic encephalitis.”

• Coding Process:

  1. The provider has diagnosed autoimmune encephalitis. The manifestation is encephalitis -> G04.81

  2. There is no confirmed antibody to code. You cannot assume one. You code only what is documented.

  3. Per AHA Coding Clinic advice (Q4 2016, p. 144), for seronegative autoimmune encephalitis, you assign only code G04.81. Do not assign D89.89 or R79.83 without a confirmed antibody.

• Final Code Assignment: G04.81

Scenario 3: Autoimmune Encephalitis with an Underlying Neoplasm

• Documentation: “Patient with known small cell lung cancer now presenting with severe memory loss and seizures. Anti-Hu antibodies positive in CSF. Diagnosis: Paraneoplastic limbic encephalitis secondary to small cell lung cancer.”

• Coding Process:

  1. Code the neoplasm first. This is a fundamental coding rule. The cancer is the underlying cause.

  2. Code for small cell lung cancer (e.g., C34.90 – Malignant neoplasm of unspecified part of unspecified bronchus or lung).

  3. Code the manifestation: encephalitis -> G04.81

  4. Code the immune mechanism and specific antibody: D89.89, R79.83

• Final Code Assignment: C34.90, G04.81, D89.89, R79.83

Scenario 4: Post-Herpes Simplex Encephalitis Autoimmune Encephalitis

• Documentation: “Child diagnosed with HSV encephalitis 4 weeks ago, completed a course of acyclovir and improved. Now readmitted with new-onset chorea and behavioral change. MRI shows new inflammation. CSF positive for anti-NMDAR antibodies. Diagnosis: Autoimmune encephalitis post-HSV infection.”

• Coding Process:

  1. This is a complex scenario with two distinct etiologies.

  2. Code the current, active disease: autoimmune encephalitis -> G04.81, D89.89, R79.83

  3. Code the history of the infectious trigger: B00.4 – Herpesviral encephalitis (and) Z86.19 – Personal history of other infectious and parasitic diseases

• Final Code Assignment: G04.81, D89.89, R79.83, B00.4, Z86.19 (Note: The sequencing would depend on the reason for the current encounter; the autoimmune encephalitis is likely the principal diagnosis).

7. The Power of Specificity: Utilizing Additional Codes

A patient with AE rarely has just one code. Capturing the full clinical picture is essential for severity adjustment and accurate reimbursement.

Capturing Manifestations:

• Seizures: Code the type of seizure (e.g., G40.309 – Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus, or G40.109 – Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus).

• Cognitive Deficits: R41.1 – Anterograde amnesia, R41.2 – Retrograde amnesia, R41.3 – Other amnesia, R41.8 – Other symptoms and signs involving cognitive functions and awareness.

• Psychiatric Symptoms: F05 – Delirium, F06.0 – Psychotic disorder due to known physiological condition, R44.0 – Auditory hallucinations, R44.3 – Visual hallucinations.

Documenting Complications:

• Status Epilepticus: G40.901 – Epilepsy, unspecified, intractable, with status epilepticus.

• Dysautonomia: G90.9 – Disorder of the autonomic nervous system, unspecified.

• Speech Problems: R47.81 – Slurred speech, R47.89 – Other speech disturbances.

• Hyponatremia: E87.1 – Hypo-osmolality and hyponatremia (common in LGI1 encephalitis).

8. Common Pitfalls and How to Avoid Them

• Pitfall 1: Misclassifying as Infectious Encephalitis. Using a code from B94.1 – Sequelae of viral encephalitis or a code from the A80-A89 block for viral encephalitis is incorrect unless an active viral infection is confirmed as the cause. AE is autoimmune, not infectious.

• Pitfall 2: Overlooking the Link to Malignancy. Failing to code a confirmed associated neoplasm as the primary diagnosis in a paraneoplastic syndrome is a major error. Always review the patient’s history and current diagnostic findings.

• Pitfall 3: Insufficient Documentation and Provider Queries. If the documentation is unclear (e.g., “encephalitis, cause unknown,” but autoimmune is suspected), the coder must initiate a provider query. A well-constructed query clarifies the diagnosis, leading to accurate coding. Example: “The patient was treated with IV steroids for encephalitis. Is this consistent with a diagnosis of autoimmune encephalitis?”

9. The Future of Coding: ICD-11 and the Evolution of Neuroinflammatory Disorders

The World Health Organization’s ICD-11, which is gradually being adopted, offers a more refined structure for neurological diseases. In ICD-11, autoimmune encephalitis has a more dedicated home:

• Code 8A45.0 – Autoimmune encephalitis is located under “Diseases of the nervous system” -> “Inflammatory diseases of the central nervous system.”

• It has multiple extension codes for specific antibodies (e.g., 8A45.00 – Anti-NMDA receptor encephalitis, 8A45.01 – Limbic encephalitis, LGI1 antibody-associated).
  This structure eliminates the need for multiple codes from different chapters and allows for more intuitive and specific coding, which will greatly benefit the tracking and management of these complex disorders.

10. Conclusion: Synthesizing Clinical Nuance with Coding Precision

Accurate ICD-10 coding for autoimmune encephalitis is a critical synthesis of clinical understanding and coding expertise. The journey from a patient’s symptoms to a finalized claim hinges on correctly applying G04.81, diligently searching for and coding the specific antibody etiology with D89.89 and R79.83, and comprehensively capturing all associated manifestations and complications. By moving beyond a single code and embracing the necessary specificity, medical coders ensure that the story of each autoimmune encephalitis patient is accurately told within the healthcare data ecosystem, driving appropriate reimbursement, robust research, and ultimately, better patient outcomes.

11. Frequently Asked Questions (FAQs)

Q1: What is the single most important code for autoimmune encephalitis?
A: The foundational code is almost always G04.81 (Other encephalitis and encephalomyelitis due to other causes). However, it is rarely used alone. Always check for a specific cause to code as well.

Q2: The physician documents “autoimmune encephalitis” but the antibody test is still pending. How do I code this?
A: If the provider has made a clinical diagnosis of autoimmune encephalitis, you should code G04.81. You cannot code a specific antibody (R79.83) until it is confirmed and documented. If the provider is still ruling it out and uses terms like “suspected” or “possible,” you may need to code the presenting symptoms (e.g., delirium, seizures) instead.

Q3: The antibody test is positive, but it’s from an outside lab and hasn’t been confirmed by our hospital’s lab. Can I code it?
A: Yes. If the treating provider has documented the positive result and is acting upon it (e.g., initiating immunotherapy), you can code the confirmed antibody. The code reflects the provider’s diagnosis and the medical record documentation.

Q4: What is the correct code for the antibody itself? I see R79.83 is for “abnormal tumor marker.”
A: This is a common point of confusion. Despite its descriptor, R79.83 is the code instructed by the ICD-10-CM Alphabetic Index for specific neural autoantibodies like anti-NMDAR. Always follow the official indexing, even if the code title seems imperfect.

Q5: How do I code a patient who has a history of autoimmune encephalitis but is now presenting for a follow-up with no active issues?
A: You would use a code from the Z86.69 – Personal history of other diseases of the nervous system and sense organs category to represent the resolved condition. You would not use an active encephalitis code (G04.81) unless the disease was still active.

12. Additional Resources

For the most accurate and up-to-date coding, always consult these primary sources:

1. ICD-10-CM Official Guidelines for Coding and Reporting (FY 2025): Published by the CDC and CMS. https://www.cdc.gov/nchs/icd/icd-10-cm.htm

2. AHA Coding Clinic for ICD-10-CM: The official source for coding advice. Critical reading for all advanced coders.

3. Autoimmune Encephalitis Alliance: A patient advocacy group with excellent clinical resources for understanding the disease. https://aealliance.org/

4. National Institute of Neurological Disorders and Stroke (NINDS) – Autoimmune Encephalitis Information Page: Provides overviews for healthcare professionals and the public. https://www.ninds.nih.gov/autoimmune-encephalitis

Date: September 19, 2025
Author: The  Health Informatics Team
Disclaimer: This article is for informational purposes only and is intended for healthcare professionals, medical coders, and health information management specialists. It is not a substitute for professional clinical judgment, current coding guidelines, or the most recent edition of the ICD-10-CM code set. Always consult official ICD-10-CM manuals, payer-specific guidelines, and clinical documentation for accurate coding and billing.